US31573L1052 - Common Stock
FIBROBIOLOGICS INC
NASDAQ:FBLG (1/2/2025, 8:00:02 PM)
After market: 1.99 +0 (+0.25%)1.985
-0.01 (-0.75%)
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. The company is headquartered in Houston, Texas and currently employs 10 full-time employees. The company went IPO on 2024-01-31. The firm operates as a biopharmaceutical company. The company is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. The company also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
FIBROBIOLOGICS INC
455 E. Medical Center Blvd, Suite 300
Houston TEXAS
P: 12816715150
Employees: 10
Website: https://fibrobiologics.com/
HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (
HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (
Here you can normally see the latest stock twits on FBLG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: